BSEBoard Meeting1d ago · 29 Aug 2026, 07:18 pm

Outcome of Board Meeting held on August 29, 2026

Salem Erode Investments Ltd · 540181

✦ AI SummaryFundraise

Salem Erode Investments Ltd has announced the outcome of its Board Meeting held on August 29, 2026, where the Board approved the proposed Rights Issue of up to 1,14,65,520 equity shares at ₹20 per share, with a record date of September 03, 2026, and a tentative schedule for the issue from September 15 to September 29, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Salem Erode Investments Ltd - 540181 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 29, 2026

Attachments (1)

📄

4eacaeea-daf4-4499-9319-2498f21bbbc8.pdf

pdf

Download →
View document text
Ref: SEC/SEIL/BSE/2026/121 Date: August 29, 2026 Scrip Code: 540181 Listing Department, BSE Limited P. J. Towers, Dalal Street, Mumbai – 400 001 Sub: Outcome of the Board Meeting held on August 29, 2026, under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "SEBI Listing Regulations") Ref: Our intimation dated August 25, 2026 regarding the Board Meeting to consider the proposed Rights Issue. Dear Sir / Madam, Further to our intimation cited above, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., August 29, 2026, which commenced at 04.00 PM and concluded at 07.00 PM, has, inter alia, considered and approved the following in connection with the proposed issue of equity shares of the Company on a rights basis to the eligible equity shareholders of the Company as on the record date ("Rights Issue"): 1. Issue Size: Issue of up to 1,14,65,520 equity shares of face value of ₹1 each ("Rights Equity Shares"), for an amount aggregating up to ₹2,293.10 Lakhs. 2. Rights Entitlement Ratio: 1 (One) Rights Equity Share(s) for every 1 (One) fully paid-up equity share(s) held by the eligible equity shareholders as on the record date. 3. Issue Price: ₹20 per Rights Equity Share (including a premium of ₹19 per share), aggregating to ₹20 per Rights Equity Share. 4. Record Date: Thursday September 03, 2026, for the purpose of determining the eligibility of shareholders entitled to apply for the Rights Equity Shares. 5. Approval of the Letter of Offer, Abridged Letter of Offer, Application Form and Rights Entitlement Letter to be filed with BSE Limited and SEBI, as applicable, in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended ("SEBI ICDR Regulations"). 6. Tentative Schedule of the Rights Issue: Particulars Tentative Date Issue Opening Date Tuesday, September 15, 2026 Last Date for On-Market Renunciation Monday, September 21, 2026 Issue Closing Date Friday, September 25, 2026 Finalisation of Basis of Allotment Monday, September 28, 2026 Date of Allotment Monday, September 28, 2026 Date of Credit of Shares Tuesday, September 29, 2026 Date of Listing on BSE Limited Tuesday, September 29, 2026 7. Any other matter incidental and connected to the Rights Issue as approved by the Board. The above is subject to receipt of requisite approvals, including from BSE Limited and SEBI, as may be applicable, and other regulatory/statutory authorities. Further, pursuant to Regulation 30 of the SEBI Listing Regulations, this intimation is being submitted within the prescribed timeline. The details as required under Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated July 11, 2023 and last updated on January 30, 2026 are enclosed as Annexure A. The trading window, which was closed with effect from August 25, 2026, shall reopen 48 hours after this outcome is disseminated to the Stock Exchange, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct on Insider Trading. Page | 2 This intimation is also being uploaded on the Company's website at www.salemerode.com. You are requested to take the above information on record. Thanking you. Yours faithfully, For Salem Erode Investments Limited Visakh T V Company Secretary M. No: A53607 Page | 3 Annexure A Disclosure under Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Dated July 11, 2023 and last updated on January 30, 2026. Particulars Details 1. Type of securities proposed to be issued (viz. equity Fully paid-up Equity Shares of the shares, convertibles etc.) face value of ₹1/- each (“Equity Shares”) 2. Type of Issuance (further public offering, rights Rights Issue issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.); 3. Total number of securities proposed to be issued or Issue of up to 1,14,65,520 equity the total amount for which the securities will be shares of face value of ₹1 each, at issued (approximately) ₹20 (including a premium of ₹19), for an amount aggregating up to ₹2,293.10 Lakhs. 4. In case of preferential issue the listed entity shall Not Applicable disclose the following additional details to the stock exchange(s) 5. In case of bonus issue the listed entity shall Not Applicable disclose the following additional details to the stock exchange(s) 6. In case of issuance of depository receipts Not Applicable (ADR/GDR) or FCCB the listed entity shall disclose following additional details to the stock exchange(s): 7. In case of issuance of debt securities or other Not Applicable nonconvertible securities the listed entity shall disclose following additional details to the stock exchange(s): 8. Any cancellation or termination of proposal for Not Applicable issuance of securities including reasons thereof Page | 4